Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT), the Center for Global Infectious Disease Research – Seattle in the United States, and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to serve multiple functions in the fight against TB.
Here’s a different reason for tobacco to be in the news. Cape Bio Pharms, a biotech company with its origins in the Biopharming Research Unit (BRU) at the University of Cape Town (UCT), has joined the global effort to create a fast and affordable antibody test for COVID-19, using a relative of the tobacco plant.
UCT alumni have designed a rig to increase production of the bottle spacers that administer metred medication dosages to patients
As COVID-19 infection and morbidity rates increase around the globe, a number of companies and academic institutions have entered the race to develop a vaccine to protect us from the lethal virus. Creating a vaccine is, however, a complex process and could take several months, if not years.